These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8022948)

  • 1. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
    George MS; Rosenstein D; Rubinow DR; Kling MA; Post RM
    Psychiatry Res; 1994 Feb; 51(2):139-46. PubMed ID: 8022948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and erythrocyte magnesium levels in patients with primary affective disorder during chronic lithium treatment.
    Dunner DL; Meltzer HL; Schreiner HC; Feigelson JL
    Acta Psychiatr Scand; 1975 Feb; 51(2):104-9. PubMed ID: 1091123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
    Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM
    Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
    Keisling R
    Arch Gen Psychiatry; 1983 Feb; 40(2):223. PubMed ID: 6401989
    [No Abstract]   [Full Text] [Related]  

  • 5. Lithium-magnesium relationship in red blood cells during lithium prophylaxis.
    Rybakowski J; Szajnerman Z
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Sep; 9(5):242-6. PubMed ID: 996088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF somatostatin in affective illness and normal volunteers.
    Rubinow DR; Gold PW; Post RM; Ballenger JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):393-400. PubMed ID: 2866561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP; Thürauf N; Mokrusch T; Korth M
    Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased neural cell adhesion molecule in the CSF of patients with mood disorder.
    Poltorak M; Frye MA; Wright R; Hemperly JJ; George MS; Pazzaglia PJ; Jerrels SA; Post RM; Freed WJ
    J Neurochem; 1996 Apr; 66(4):1532-8. PubMed ID: 8627309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
    Davis JM; Janicak PG; Hogan DM
    Acta Psychiatr Scand; 1999 Dec; 100(6):406-17. PubMed ID: 10626918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet monoamine oxidase activity in affective disorders.
    Reveley MA; Glover V; Sandler M; Coppen A
    Psychopharmacology (Berl); 1981; 73(3):257-60. PubMed ID: 6787645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of carbamazepine in affective disorders].
    Beresewicz M
    Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients.
    Frye MA; Denicoff KD; Bryan AL; Smith-Jackson EE; Ali SO; Luckenbaugh D; Leverich GS; Post RM
    Am J Psychiatry; 1999 Dec; 156(12):1909-14. PubMed ID: 10588404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum drug level monitoring in affective disorders.
    Krska J; Corner DA
    J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
    Nolen WA; Jansen GS; Broekman M
    Pharmacopsychiatry; 1988 Sep; 21(5):252-4. PubMed ID: 3227056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.
    George MS; Guidotti A; Rubinow D; Pan B; Mikalauskas K; Post RM
    Biol Psychiatry; 1994 May; 35(10):775-80. PubMed ID: 8043707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
    Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
    Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year follow-up of thyroid function during lithium treatment.
    Bocchetta A; Cherchi A; Loviselli A; Mossa P; Velluzzi F; Derai R; Del Zompo M
    Acta Psychiatr Scand; 1996 Jul; 94(1):45-8. PubMed ID: 8841676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.